MarketInOut Stock Screener Log In | Sign Up

Gilead Sciences Inc

XETRA • Healthcare • Drug Manufacturers - General • Quote as of 10/30/2026
Gilead Sciences Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeXETRA
Market Capitalization191,409 mln
Float1,238 mln
Earnings Date10/29/2026

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-3.98
Highly reliable

Relative Strength

98 / 100
Top performer

Debt / Equity

2.03
Very high leverage

Pre-Tax Margin

-8%
Marginally loss-making

ROE

-20.87
Deeply negative

Business Description

Gilead Sciences is an American drug company focused on developing and selling treatments for diseases where patients have few or no good options. Its product lineup spans HIV, hepatitis B and C, certain cancers, fungal infections, and COVID-19, with medicines sold across the United States, Europe, and other markets worldwide. The company works alongside a broad network of research and pharmaceutical partners to discover new therapies, including cutting-edge cancer treatments and small molecule drugs. Founded in 1987 and based in Foster City, California, Gilead continues to expand its pipeline through both internal research and external collaborations.

Key Fundamentals

EPS-2.69
ROE-20.87
RPS22.30
ROIC26.55
ROA-7.03
Interest Cover11.87
EBITDA, mln466
EV / EBITDA386
EV / EBIT-135
Revenue, mln26,745
EV / Revenue6.61

Quote Details

Last 154.32
Change 9.64 (6.66%)
Open 150.80
Volume 4,609
Turnover 711,261
Average Volume 1,272.76

Financial Ratios

Pre-Tax Profit Margin-8
Leverage Ratio3.94
Current Ratio1.32
Price / Book16.35
Price / Cash Flow14.64
Price / Free Cash Flow15.22
Debt / Equity2.03
Price / Sales6.87
PEG Ratio3.56

Financial Strength

Altman Z-Score3.9
Piotroski F-Score 5 / 9
Beneish M-Score-3.98
Price to Intrinsic Value2.07
Shiller PE Ratio46.12

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 10.21% 99 / 100   
1 Month 17.21% 97 / 100   
2 Months 32.43% 98 / 100   
6 Months 36.22% 96 / 100   
1 Year 53.22% 95 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog